Spots Global Cancer Trial Database for Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Official Title: Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
Study ID: NCT01249066
Conditions
Interventions
Study Description
Brief Summary: AMP-activated protein kinase (AMPK) is an evolutionally conserved protein kinase that serves as an energy guardian to help cells adapt to various metabolic stress including hypoxia. Because the role of AMPK in cancers has not been fully elucidated, in this study we investigated the expression and activation of AMPK in lung adenocarcinoma (LADC) cells and tissue.
Detailed Description:
Eligibility
Minimum Age: 25 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Fang Hsin Yuan, Taichung, , Taiwan
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
